title: The roles of galactitol, galactose-1-phosphate, and phosphoglucomutase in galactose-induced toxicity in Saccharomyces cerevisiae.
abstract: The uptake and catabolism of galactose by the yeast Saccharomyces cerevisiae is much lower than for glucose and fructose, and in applications of this yeast for utilization of complex substrates that contain galactose, for example, lignocellulose and raffinose, this causes prolonged fermentations. Galactose is metabolized via the Leloir pathway, and besides the industrial interest in improving the flux through this pathway it is also of medical relevance to study the Leloir pathway. Thus, genetic disorders in the genes encoding galactose-1-phosphate uridylyltransferase or galactokinase result in galactose toxicity both in patients with galactosemia and in yeast. In order to elucidate galactose related toxicity, which may explain the low uptake and catabolic rates of S. cerevisiae, we have studied the physiological characteristics and intracellular metabolite profiles of recombinant S. cerevisiae strains with improved or impaired growth on galactose. Aerobic batch cultivations on galactose of strains with different combinations of overexpression of the genes GAL1, GAL2, GAL7, and GAL10, which encode proteins that together convert extracellular galactose into glucose-1-phosphate, revealed a decrease in the maximum specific growth rate when compared to the reference strain. The hypothesized toxic intermediate galactose-1-phosphate cannot be the sole cause of galactose related toxicity, but indications were found that galactose-1-phosphate might cause a negative effect through inhibition of phosphoglucomutase. Furthermore, we show that galactitol is formed in S. cerevisiae, and that the combination of elevated intracellular galactitol concentration, and the ratio between galactose-1-phosphate concentration and phosphoglucomutase activity seems to be important for galactose related toxicity causing decreased growth rates.
authors.affiliation: Center for Microbial Biotechnology, BioCentrum-DTU, Technical University of Denmark, Building 223, Søltofts Plads, DK-2800 Kgs. Lyngby, Denmark.
authors.forename: Willem A
authors.initials: WA
authors.lastname: de Jongh
authors.forename: Christoffer
authors.initials: C
authors.lastname: Bro
authors.forename: Simon
authors.initials: S
authors.lastname: Ostergaard
authors.forename: Birgitte
authors.initials: B
authors.lastname: Regenberg
authors.forename: Lisbeth
authors.initials: L
authors.lastname: Olsson
authors.forename: Jens
authors.initials: J
authors.lastname: Nielsen
mesh_terms: D003470:Culture Media; D004376:Galactitol / Q000378:metabolism*; D005686:Galactokinase / Q000235:genetics; D005690:Galactose / Q000633:toxicity*; D005695:Galactosephosphates / Q000378:metabolism*; D009097:Multienzyme Complexes; D010733:Phosphoglucomutase / Q000378:metabolism*; D010957:Plasmids; D012441:Saccharomyces cerevisiae / Q000187:drug effects / Q000201:enzymology / Q000235:genetics / Q000378:metabolism*; D029701:Saccharomyces cerevisiae Proteins / Q000235:genetics; D015534:Trans-Activators / Q000235:genetics
chemical_list: D003470:Culture Media; C518355:GAL10 protein, S cerevisiae; D005695:Galactosephosphates; D009097:Multienzyme Complexes; D029701:Saccharomyces cerevisiae Proteins; D015534:Trans-Activators; D004376:Galactitol; C029973:galactose-1-phosphate; C524219:GAL1 protein, S cerevisiae; D005686:Galactokinase; D010733:Phosphoglucomutase; D005690:Galactose